Search Results

There are 9849 results for: content related to: Counterfeit Medications: Impurities in the American Drug Supply

  1. You have full text access to this OnlineOpen article
    Substandard drugs: a potential crisis for public health

    British Journal of Clinical Pharmacology

    Volume 78, Issue 2, August 2014, Pages: 218–243, Atholl Johnston and David W. Holt

    Article first published online : 21 JUL 2014, DOI: 10.1111/bcp.12298

  2. Role of Pharmacogenetics in Registration Processes

    Pharmacogenetics and Individualized Therapy

    Myong-Jin Kim, Issam Zineh, Shiew-Mei Huang, Lawrence J. Lesko, Pages: 461–475, 2012

    Published Online : 8 AUG 2012, DOI: 10.1002/9781118116494.ch17

  3. Turning Points and Negotiation: The Case of the 2007–2008 Writers' Strike

    Negotiation and Conflict Management Research

    Volume 7, Issue 3, August 2014, Pages: 188–212, Linda L. Putnam and Ryan P. Fuller

    Article first published online : 22 JUL 2014, DOI: 10.1111/ncmr.12032

  4. The State of the Art in the Development of Biosimilars

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 3, March 2012, Pages: 405–417, Mark McCamish and Gillian Woollett

    Article first published online : 8 FEB 2012, DOI: 10.1038/clpt.2011.343

  5. Assessing the problem of counterfeit medications in the United Kingdom

    International Journal of Clinical Practice

    Volume 66, Issue 3, March 2012, Pages: 241–250, G. Jackson, S. Patel and S. Khan

    Article first published online : 9 NOV 2011, DOI: 10.1111/j.1742-1241.2011.02826.x

  6. Catalyzing the critical path initiative: FDA's progress in drug development activities

    Clinical Pharmacology & Therapeutics

    A Parekh, S Buckman-Garner, S McCune, R ONeill, M Geanacopoulos, S Amur, C Clingman, R Barratt, M Rocca, I Hills and J Woodcock

    Article first published online : 28 JAN 2015, DOI: 10.1002/cpt.42

  7. Opportunities and Challenges of Safety Biomarker Qualification: Perspectives from the Predictive Safety Testing Consortium

    Drug Development Research

    Volume 74, Issue 2, March 2013, Pages: 112–126, Eslie H. Dennis, Elizabeth G. Walker, Amanda F. Baker and Richard T. Miller

    Article first published online : 22 FEB 2013, DOI: 10.1002/ddr.21070

  8. Formulary Decisions: Then and Now

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 30, Issue 6P2, June 2010, Pages: 35s–41s, Bradley A. Boucher

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.30.pt2.35S

  9. You have free access to this content
    Requirement for safety monitoring for approved multiple sclerosis therapies: an overview

    Clinical & Experimental Immunology

    Volume 175, Issue 3, March 2014, Pages: 397–407, P. S. Rommer, U. K. Zettl, B. Kieseier, H.-P. Hartung, T. Menge, E. Frohman, B. M. Greenberg, B. Hemmer and O. Stüve

    Article first published online : 4 FEB 2014, DOI: 10.1111/cei.12206

  10. Design and Implementation of Surveys to Assess Patient and Healthcare Provider Understanding of Risks and Safe Use Conditions

    Mann's Pharmacovigilance

    Kelly Hollis, Alicia Gilsenan, Pages: 769–784, 2014

    Published Online : 4 APR 2014, DOI: 10.1002/9781118820186.ch49

  11. Advancing the Science of Medicines Regulation: The Role of the 21st-Century Medicines Regulator

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 4, October 2012, Pages: 486–493, M M Lumpkin, H-G Eichler, A Breckenridge, M A Hamburg, T Lönngren and K Woods

    Article first published online : 5 SEP 2012, DOI: 10.1038/clpt.2012.146

  12. Unintended effects of orphan product designation for rare neurological diseases

    Annals of Neurology

    Volume 72, Issue 4, October 2012, Pages: 481–490, Sinéad M. Murphy, Araya Puwanant, Robert C. Griggs and the Consortium for Clinical Investigations of Neurological Channelopathies (CINCH) and Inherited Neuropathies Consortium (INC) Consortia of the Rare Disease Clinical Research Network

    Article first published online : 29 OCT 2012, DOI: 10.1002/ana.23672

  13. You have full text access to this OnlineOpen article
    Development of Federally Mandated Risk Evaluation and Mitigation Strategies (REMS) for Transmucosal Immediate-Release Fentanyl Products

    Pain Practice

    Volume 13, Issue 4, April 2013, Pages: 259–263, Joseph V. Pergolizzi, Christopher G. Gharibo, Jeffrey A. Gudin and Srinivas R. Nalamachu

    Article first published online : 6 MAR 2013, DOI: 10.1111/papr.12040

  14. Understanding the regulatory hurdles for antibacterial drug development in the post-Ketek world

    Annals of the New York Academy of Sciences

    Volume 1241, Issue 1, December 2011, Pages: 153–161, Roger M. Echols

    Article first published online : 22 DEC 2011, DOI: 10.1111/j.1749-6632.2011.06300.x

  15. You have free access to this content
    Forecast verification: current status and future directions

    Meteorological Applications

    Volume 15, Issue 1, March 2008, Pages: 3–18, Dr B. Casati, L. J. Wilson, D. B. Stephenson, P. Nurmi, A. Ghelli, M. Pocernich, U. Damrath, E. E. Ebert, B. G. Brown and S. Mason

    Article first published online : 20 MAR 2008, DOI: 10.1002/met.52

  16. Melamine Contamination

    Standard Article

    Encyclopedia of Bioterrorism Defense

    Leila Heintzelman

    Published Online : 15 JUL 2011, DOI: 10.1002/0471686786.ebd0171

  17. The Pracademic and the Fed: The Leadership of Chairman Benjamin Bernanke

    Public Administration Review

    Volume 70, Issue 1, January/February 2010, Pages: 142–150, Anne M. Khademian

    Article first published online : 24 DEC 2009, DOI: 10.1111/j.1540-6210.2009.02118.x

  18. The Federal Reserve System and the Credit Crisis

    Public Administration Review

    Volume 69, Issue 4, July/August 2009, Pages: 623–631, J. Kevin Corder

    Article first published online : 6 JUL 2009, DOI: 10.1111/j.1540-6210.2009.02011.x

  19. You have free access to this content
    Novel Treatments for Cardiovascular Disease Prevention

    Cardiovascular Therapeutics

    Volume 30, Issue 5, October 2012, Pages: 257–263, Mark D. Huffman and Deepak Bhatnagar

    Article first published online : 31 MAY 2011, DOI: 10.1111/j.1755-5922.2011.00280.x

  20. Applications of Pharmacogenetics in Pharmaceutical Research and Development

    Pharmacogenetics and Individualized Therapy

    Daniel K. Burns, Scott S. Sundseth, Pages: 437–460, 2012

    Published Online : 8 AUG 2012, DOI: 10.1002/9781118116494.ch16